Literature DB >> 31122669

Pembrolizumab induced toxic epidermal necrolysis.

Rohit Kumar1, Shruti Bhandari2.   

Abstract

Entities:  

Keywords:  Bullous disease; Cancer treatment related adverse effects; Dermatologic emergency; Immunotherapy related adverse effects

Mesh:

Substances:

Year:  2019        PMID: 31122669     DOI: 10.1016/j.currproblcancer.2019.05.001

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  1 in total

1.  [Bullous drug reaction after pembrolizumab administration: two case reports].

Authors:  L Golle; C Michl; B Kreft
Journal:  Dermatologie (Heidelb)       Date:  2022-06-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.